Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms

Clinical Endocrinology

Volumn 65, Issue 6, 2006, Pages 792-799

  Hofland, J ^a   Timmerman, M A ^a   De Herder, W W ^a   Van Schaik, R H N ^a   De Krijger, R R ^a   De Jong, F H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXY 1 METHYLTETRALIN; ACTIVIN; BINDING PROTEIN; CYTOCHROME P450 17; FOLLISTATIN; INHIBIN; INHIBIN A; INHIBIN B; MESSENGER RNA; NUCLEAR RECEPTOR COACTIVATOR 2;

ADRENAL CORTEX; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ADULT; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTIVIN RECEPTORS, TYPE II; ACTIVINS; ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADRENOCORTICAL CARCINOMA; ADULT; CARRIER PROTEINS; FEMALE; FOLLISTATIN; GENE EXPRESSION; HUMANS; HYPERPLASIA; INHIBIN-BETA SUBUNITS; INHIBINS; MALE; MIDDLE AGED; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; STEROID 17-ALPHA-HYDROXYLASE;

EID: 33751089563     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02668.x     Document Type: Article

References (46)

1. Kloos, R.T., Gross, M.D., Francis, I.R., Korobkin, M. & Shapiro, B. (1995) Incidentally discovered adrenal masses. Endocrine Reviews, 16, 460-484.
2. National Institutes of Health (2002) NIH State-of-the-Science Statement on management of the clinically inapparent adrenal mass ('incidentaloma'). NIH Consensus State-of-the-Science Statements, 19, 1-25.
3. Arnaldi, G., Masini, A.M., Giacchetti, G., Taccaliti, A., Faloia, E. & Mantero, F. (2000) Adrenal incidentaloma. Brazilian Journal of Medical and Biological Research, 33, 1177-1189.
4. Latronico, A.C. & Chrousos, G.P. (1997) Extensive personal experience: adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism, 82, 1317-1324.
5. Bornstein, S.R., Stratakis, C.A. & Chrousos, G.P. (1999) Adrenocortical tumors: recent advances in basic concepts and clinical management. Annals of Internal Medicine, 130, 759-771.
6. Matzuk, M.M., Finegold, M.J., Mather, J.P., Krummen, L., Lu, H. & Bradley, A. (1994) Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 91, 8817-8821.
7. de Jong, F.H. (1979) Inhibin - fact or artifact. Molecular and Cellular Endocrinology, 13, 1-10.
8. Risbridger, G.P., Schmitt, J.F. & Robertson, D.M. (2001) Activins and inhibins in endocrine and other tumors. Endocrine Reviews, 22, 836-858.
9. Pangas, S.A. & Woodruff, T.K. (2000) Activin signal transduction pathways. Trends in Endocrinology and Metabolism, 11, 309-314.
10. Lewis, K.A., Gray, P.C., Blount, A.L., MacConell, L.A., Wiater, E., Bilezikjian, L.M. & Vale, W. (2000) Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature, 404, 411-414.
11. Martens, J.W., de Winter, J.P., Timmerman, M.A., McLuskey, A., van Schaik, R.H., Themmen, A.P. & de Jong, F.H. (1997) Inhibin interferes with activin signaling at the level of the activin receptor complex in Chinese hamster ovary cells. Endocrinology, 138, 2928-2936.
12. Nakamura, T., Takio, K., Eto, Y., Shibai, H., Titani, K. & Sugino, H. (1990) Activin-binding protein from rat ovary is follistatin. Science, 247, 836-838.
13. Welt, C., Sidis, Y., Keutmann, H. & Schneyer, A. (2002) Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Experimental Biology and Medicine (Maywood), 227, 724-752.
14. Haji, M., Nishi, Y., Tanaka, S., Ohashi, M., Sekiya, K., Hasegawa, Y., Igarashi, M., Sasamoto, S. & Nawata, H. (1991) Evidence for the secretion of inhibin-like immunoreactivity from cultured human adrenal cells. Journal of Endocrinology, 128, R13-R16.
15. McCluggage, W.G., Burton, J., Maxwell, P. & Sloan, J.M. (1998) Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin. Journal of Clinical Pathology, 51, 114-116.
16. Munro, L.M., Kennedy, A. & McNicol, A.M. (1999) The expression of inhibin/activin subunits in the human adrenal cortex and its tumours. Journal of Endocrinology, 161, 341-347.
17. Spencer, S.J., Rabinovici, J., Mesiano, S., Goldsmith, P.C. & Jaffe, R.B. (1992) Activin and inhibin in the human adrenal gland. Regulation and differential effects in fetal and adult cells. Journal of Clinical Investigation, 90, 142-149.
18. Vanttinen, T., Kuulasmaa, T., Liu, J. & Voutilainen, R. (2002) Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells. Journal of Clinical Endocrinology and Metabolism, 87, 4257-4263.
19. Vanttinen, T., Liu, J., Kuulasmaa, T., Kivinen, P. & Voutilainen, R. (2003) Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis. Journal of Endocrinology, 178, 479-489.
20. Voutilainen, R., Eramaa, M. & Ritvos, O. (1991) Hormonally regulated inhibin gene expression in human fetal and adult adrenals. Journal of Clinical Endocrinology and Metabolism, 73, 1026-1030.
21. Arola, J., Liu, J., Heikkila, P., Ilvesmaki, V., Salmenkivi, K., Voutilainen, R. & Kahri, A.I. (2000) Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm. Journal of Endocrinology, 165, 223-229.
22. Nishi, Y., Haji, M., Tanaka, S., Yanase, T., Takayanagi, R., Etoh, Y. & Nawata, H. (1992) Human recombinant activin-A modulates the steroidogenesis of cultured bovine adrenocortical cells. Journal of Endocrinology, 132, R1-R4.
23. Suzuki, J., Otsuka, F., Inagaki, K., Takeda, M., Ogura, T. & Makino, H. (2004) Novel action of activin and bone morphogenetic protein in regulating aldosterone production by human adrenocortical cells. Endocrinology, 145, 639-649.
24. Nishi, Y., Haji, M., Takayanagi, R., Yanase, T., Ikuyama, S. & Nawata, H. (1995) In vivo and in vitro evidence for the production of inhibin-like immunoreactivity in human adrenocortical adenomas and normal adrenal glands: relatively high secretion from adenomas manifesting Cushing's syndrome. European Journal of Endocrinology, 132, 292-299.
25. Rich, N., Gaston, V., Le Bouc, Y. & Gicquel, C. (2002) Expression of the gene for the alpha-subunit of inhibin in human adrenocortical tumours. Hormone Research, 57, 43-47.
26. van Slooten, H., Schaberg, A., Smeenk, D. & Moolenaar, A.J. (1985) Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer, 55, 766-773.
27. Beuschlein, F., Looyenga, B.D., Bleasdale, S.E., Mutch, C., Bavers, D.L., Parlow, A.F., Nilson, J.H. & Hammer, G.D. (2003) Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Molecular and Cellular Biology, 23, 3951-3964.
28. He, Z.Y., Liu, H.C., Mele, C.A., Barmat, L., Veeck, L.L., Davis, O. & Rosenwaks, Z. (1999) Expression of inhibin/activin subunits and their receptors and binding proteins in human preimplantation embryos. Journal of Assisted Reproduction and Genetics, 16, 73-80.
29. Kananen, K., Markkula, M., Mikola, M., Rainio, E.M., McNeilly, A. & Huhtaniemi, I. (1996) Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin alpha-subunit gene. Molecular Endocrinology, 10, 1667-1677.
30. Salmenkivi, K., Arola, J., Voutilainen, R., Ilvesmaki, V., Haglund, C., Kahri, A.I., Heikkila, P. & Liu, J. (2001) Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis. Journal of Clinical Endocrinology and Metabolism, 86, 2231-2235.
31. Tricarico, C., Pinzani, P., Bianchi, S., Paglierani, M., Distante, V., Pazzagli, M., Bustin, S.A. & Orlando, C. (2002) Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Analytical Biochemistry, 309, 293-300.
32. Wang, E.Y., Ma, E.Y. & Woodruff, T.K. (2003) Activin signal transduction in the fetal rat adrenal gland and in human H295R cells. Journal of Endocrinology, 178, 137-148.
33. Pelkey, T.J., Frierson, H.F. Jr, Mills, S.E. & Stoler, M.H. (1998) The alpha subunit of inhibin in adrenal cortical neoplasia. Modern Pathology, 11, 516-524.
34. Lund, J., Ahlgren, R., Wu, D.H., Kagimoto, M., Simpson, E.R. & Waterman, M.R. (1990) Transcriptional regulation of the bovine CYP17 (P-450(17)alpha) gene. Identification of two cAMP regulatory regions lacking the consensus cAMP-responsive element (CRE). Journal of Biological Chemistry, 265, 3304-3312.
35. DiMuccio, T., Mukai, S.T., Clelland, E., Kohli, G., Cuartero, M., Wu, T. & Peng, C. (2005) Cloning of a second form of activin-betaA cDNA and regulation of activin-betaA subunits and activin type II receptor mRNA expression by gonadotropin in the zebrafish ovary. General and Comparative Endocrinology, 143, 287-299.
36. Klaij, I.A., Toebosch, A.M., Themmen, A.P., Shimasaki, S., de Jong, F.H. & Grootegoed, J.A. (1990) Regulation of inhibin alpha- and beta B-subunit mRNA levels in rat Sertoli cells. Molecular and Cellular Endocrinology, 68, 45-52.
37. Liu, J., Kuulasmaa, T., Kosma, V.M., Butzow, R., Vanttinen, T., Hyden-Granskog, C. & Voutilainen, R. (2003) Expression of betaglycan, an inhibin coreceptor, in normal human ovaries and ovarian sex cord-stromal tumors and its regulation in cultured human granulosa-luteal cells. Journal of Clinical Endocrinology and Metabolism, 88, 5002-5008.
38. Pang, Y. & Ge, W. (2002) Gonadotropin regulation of activin betaA and activin type IIA receptor expression in the ovarian follicle cells of the zebrafish, Danio rerio. Molecular and Cellular Endocrinology, 188, 195-205.
39. Aloi, J.A., Marshall, J.C., Yasin, M., Gilrain, J.T., Haisenleder, D.J. & Dalkin, A.C. (1997) Ovarian activin receptor subtype and follistatin gene expression in rats: reciprocal regulation by gonadotropins. Biology of Reproduction, 56, 1565-1569.
40. Rosenberg, D., Groussin, L., Jullian, E., Perlemoine, K., Medjane, S., Louvel, A., Bertagna, X. & Bertherat, J. (2003) Transcription factor 3′,5′-cyclic adenosine 5'-monophosphate-responsive element-binding protein (CREB) is decreased during human adrenal cortex tumorigenesis and fetal development. Journal of Clinical Endocrinology and Metabolism, 88, 3958-3965.
41. Peri, A., Luciani, P., Conforti, B., Baglioni-Peri, S., Cioppi, F., Crescioli, C., Ferruzzi, P., Gelmini, S., Arnaldi, G., Nesi, G., Serio, M., Mantero, F. & Mannelli, M. (2001) Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. Journal of Clinical Endocrinology and Metabolism, 86, 5443-5449.
42. Groussin, L., Massias, J.F., Bertagna, X. & Bertherat, J. (2000) Loss of expression of the ubiquitous transcription factor cAMP response element-binding protein (CREB) and compensatory overexpression of the activator CREMtau in the human adrenocortical cancer cell line H295R. Journal of Clinical Endocrinology and Metabolism, 85, 345-354.
43. Miller, W.L. (1988) Molecular biology of steroid hormone synthesis. Endocrine Reviews, 9, 295-318.
44. Levine, A.C., Mitty, H.A. & Gabrilove, J.L. (1988) Steroid content of the peripheral and adrenal vein in Cushing's syndrome due to adrenocortical adenoma and carcinoma. Journal of Urology, 140, 11-15.
45. Hofland, L.J., van der Hoek, J., van Koetsveld, P.M., de Herder, W.W., Waaijers, M., Sprij-Mooij, D., Bruns, C., Weckbecker, G., Feelders, R., van der Lely, A.J., Beckers, A. & Lamberts, S.W. (2004) The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro. Journal of Clinical Endocrinology and Metabolism, 89, 1577-1585.
46. Fallo, F., Pezzi, V., Barzon, L., Mulatero, P., Veglio, F., Sonino, N. & Mathis, J.M. (2002) Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas. European Journal of Endocrinology, 147, 795-802.